Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalance of Temporomandibular Joint Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04780711
Recruitment Status : Recruiting
First Posted : March 3, 2021
Last Update Posted : April 8, 2021
Sponsor:
Information provided by (Responsible Party):
Elif yaksi, Abant Izzet Baysal University

Brief Summary:
Temporomandibular joint (TMJ) disorders are common problems in the society and involve the masticator muscles, jaw joint and related structures. Since TMJ disorders affect functions such as eating and speaking, they can cause important problems in the daily life of the patient. Therefore, its diagnosis and treatment are of great importance. In the treatment of these patients, methods such as analgesic and anti-inflammatory drugs, splint, exercise, physical therapy modalities can be applied.

Condition or disease
Temporomandibular Joint Disorders

Detailed Description:
Although the prevalence of TMJ disease detected in the community is between 40-60%, the rate of symptoms or clinical findings was reported to be 87% in a study including 1040 people. Incomplete clarification of the etiology and pathogenesis, the lack of standard diagnostic and treatment approaches cause patients to learn to live with this problem, and severe pain and limitation of movement cause a decrease in quality of life and loss of workforce. Specific pathologies such as systemic inflammatory diseases, tumor, fracture, developmental anomaly cause temporomandibular joint diseases. It also causes a wider group of non-specific TMB originating from the musculoskeletal system.When the literature was reviewed, no publications on the frequency of TMJ joint disease were found in medical faculty students.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Prevalance of Temporomandibular Joint Disease in Medical School Students
Actual Study Start Date : March 20, 2021
Estimated Primary Completion Date : May 20, 2021
Estimated Study Completion Date : June 1, 2021

Resource links provided by the National Library of Medicine


Group/Cohort
Diagnostic Group
Demographic data, symptoms for TMJ of the students will be recorded. Physical examination will be included range of motion of temporomandibular joint, right and left TMJ lateral range of motion, whether there is a gradual opening, during deflection and deviation during the opening and subluxation for palpation and measurements. Opening and closing clicks, crepitation and popping will be recorded during palpation. Deep palpation of the skin, masseter and temporal muscles will be determined, posture analysis will be recorded and dental interventions, missing teeth, orthodontic treatments and bruxism histories will be taken. An appropriate diagnosis will be determined for students who are found to have pathology as a result of all these examinations and information about this diagnosis will be provided.



Primary Outcome Measures :
  1. Mouth opening [ Time Frame: Baseline ]
    The patient opens her mouth to the maximum, the lower border of the anterior upper teeth and the distance to the upper border of the lower teeth are measured.

  2. Tenderness in the masseter and temporal muscles on deep palpation [ Time Frame: Baseline ]
    Tenderness in the masseter and temporal muscles on deep palpation

  3. Click in the temporomandibular joint [ Time Frame: Baseline ]
    The patient's temporomandibular joint is palpated, and it is checked whether there is click or popping when opening or closing the mouth.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
We planned to include 500 volunteer students between the ages of 18-35, studying at Bolu Abant Izzet Baysal University Faculty of Medicine, with or without TMJ symptoms and agreeing to participate in the study.
Criteria

Inclusion Criteria:

  • Being a medical student
  • Being between the ages of 18-35

Exclusion Criteria:

  • Students who do not want to participate in the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04780711


Contacts
Layout table for location contacts
Contact: Elif Yakşi, md +905069078505 elifyaksi@hotmail.com

Locations
Layout table for location information
Turkey
Elif Yakşi Recruiting
Bolu, Turkey, 14030
Contact: Elif Yakşi, M.D    05069078505    elifyaksi@hotmail.com   
Principal Investigator: Elif Yakşi, MD         
Principal Investigator: Muhammed Balcı, MD         
Principal Investigator: Mustafa Fatih Yaşar, MD         
Sponsors and Collaborators
Abant Izzet Baysal University
Investigators
Layout table for investigator information
Principal Investigator: Elif Yakşi, MD Abant İzzet Baysal University Medical Faculty
Layout table for additonal information
Responsible Party: Elif yaksi, Medical Doctor, Abant Izzet Baysal University
ClinicalTrials.gov Identifier: NCT04780711    
Other Study ID Numbers: AIBU-FTR-EY-01
First Posted: March 3, 2021    Key Record Dates
Last Update Posted: April 8, 2021
Last Verified: April 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Elif yaksi, Abant Izzet Baysal University:
Temporomandibular Joint Disorders
Additional relevant MeSH terms:
Layout table for MeSH terms
Joint Diseases
Temporomandibular Joint Disorders
Temporomandibular Joint Dysfunction Syndrome
Musculoskeletal Diseases
Craniomandibular Disorders
Mandibular Diseases
Jaw Diseases
Muscular Diseases
Stomatognathic Diseases
Myofascial Pain Syndromes